Painting a new picture of personalised medicine for diabetes

[1]  P. Gonzalez-Alegre,et al.  Towards precision medicine , 2017 .

[2]  M. McCarthy,et al.  Exposing the exposures responsible for type 2 diabetes and obesity , 2016, Science.

[3]  R. Leslie,et al.  Should There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies , 2016, Current Diabetes Reports.

[4]  Stephen C. J. Parker,et al.  The genetic architecture of type 2 diabetes , 2016, Nature.

[5]  K. Owen.  Treating young adults with type 2 diabetes or monogenic diabetes. , 2016, Best practice & research. Clinical endocrinology & metabolism.

[6]  S. Grant,et al.  The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema , 2016, Diabetes Care.

[7]  E. Segal,et al.  Personalized Nutrition by Prediction of Glycemic Responses , 2015, Cell.

[8]  Benjamin S. Glicksberg,et al.  Identification of type 2 diabetes subgroups through topological analysis of patient similarity , 2015, Science Translational Medicine.

[9]  Tanya M. Teslovich,et al.  Genetic fine-mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci , 2015, Nature Genetics.

[10]  Inês Barroso,et al.  Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity , 2014, Diabetes.

[11]  Stefan Johansson,et al.  Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes , 2013, Nature Genetics.

[12]  C. Julier,et al.  GLIS3, a Susceptibility Gene for Type 1 and Type 2 Diabetes, Modulates Pancreatic Beta Cell Apoptosis via Regulation of a Splice Variant of the BH3-Only Protein Bim , 2013, PLoS genetics.

[13]  B. Shields,et al.  Home urine C‐peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes , 2012, Pediatric diabetes.

[14]  B. Shields,et al.  The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes , 2012, Diabetologia.

[15]  M. McCarthy,et al.  A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes , 2011, Diabetologia.

[16]  Mark I. McCarthy,et al.  Identification of an imprinted master trans-regulator at the KLF14 locus related to multiple metabolic phenotypes , 2011, Nature Genetics.

[17]  Charles Auffray,et al.  Predictive, preventive, personalized and participatory medicine: back to the future , 2010, Genome Medicine.

[18]  Ayellet V. Segrè,et al.  Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis , 2010, Nature Genetics.

[19]  L. Groop,et al.  Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes , 2008, Diabetes.

[20]  Gale Ea,et al.  Declassifying diabetes , 2006 .

[21]  E. Gale.  Declassifying diabetes , 2006, Diabetologia.

[22]  Brämer Gr.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[23]  L. Frank.  Diabetes mellitus in the texts of old Hindu medicine (Charaka, Susruta, Vagbhata). , 1957, The American journal of gastroenterology.

[24]  Frank Ll.  Diabetes mellitus in the texts of old Hindu medicine (Charaka, Susruta, Vagbhata). , 1957 .